依维莫司
医学
肾细胞癌
肿瘤科
内科学
癌症研究
作者
Robert Dreicer,FACP. FACP.
出处
期刊:NEJM Journal Watch
日期:2008-07-29
卷期号:2008
被引量:9
标识
DOI:10.1056/oh200807290000001
摘要
During the last few years, three new agents have been approved by the FDA for the management of advanced renal cell carcinoma (RCC): sunitinib (Sutent)
科研通智能强力驱动
Strongly Powered by AbleSci AI